#CreatorPad Investing.com -- The stock of Windtree Therapeutics (NASDAQ:WINT) rose by 4.9% after the biotechnology company announced that it secured a common stock purchase agreement of up to $500 million to establish a credit line to support its investment strategy in the cryptocurrency BNB.